FOXO1 levels are elevated in obesity, and mice with reduced endothelial expression of FOXO1 had improved vascular remodelling in AT and enhanced glucose tolerance [48]. Here, FOXO1 is linked to obesity due to melanocortin 4 receptor deficiency.